skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Analysis of angiotensin II binding to human platelets: Differences in young and old subjects

Journal Article · · Journal of Gerontology; (USA)
; ; ;  [1]
  1. William S. Middleton Memorial VA Hospital, Madison, WI (USA)

We examined the binding of radiolabeled angiotensin II (AII) to human platelets to characterize the apparent increase in AII receptors observed in older subjects. At 22{degrees}C, the amount of radioactivity associated with platelets from older subjects increased continuously for more than 2 hours. The same amount of radioactivity was displaced by addition of unlabeled AII at 30 min and 60 min. In the presence of phenylarsine oxide, in the cold, or when labeled antagonist was the ligand, binding came to equilibrium by 30 min. High pressure liquid chromatography demonstrated that {sup 125}I-AII was the major radioactive compound in the supernatant and platelets after incubation, but the platelets also contained radiolabeled AII fragments. Thus, some degradation accompanied interaction of AII and platelets. Phenylarsine oxide did not prevent degradation of bound AII, suggesting that degradation precedes internalization. On average, maximum binding was greater in older subjects whether platelets were incubated with {sup 125}I-AII alone, with {sup 125}I-AII and phenylarsine oxide to prevent internalization, or when the competitive inhibitor {sup 125}I-sar1,ile8-AII was the radioligand. Variability of binding among subjects also increased with age. Thus, platelets bind, degrade, and internalize AII, and the three processes occur to a greater extent in platelets from some, but not all older subjects.

OSTI ID:
6969724
Journal Information:
Journal of Gerontology; (USA), Vol. 45:2; ISSN 0022-1422
Country of Publication:
United States
Language:
English

Similar Records

Glial high-affinity binding site with specificity for angiotensin II not angiotensin III: a possible N-terminal-specific converting enzyme
Journal Article · Wed Jan 01 00:00:00 EST 1986 · J. Cardiovasc. Pharmacol.; (United States) · OSTI ID:6969724

Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin
Journal Article · Tue Sep 01 00:00:00 EDT 1987 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:6969724

Oxidant injury increases cell surface receptor binding of angiotensin II to pulmonary artery endothelial cells
Journal Article · · Journal of Biochemical Toxicology; (United States) · OSTI ID:6969724